Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:52 UTC
Update Date2022-03-07 02:52:03 UTC
HMDB IDHMDB0015628
Secondary Accession Numbers
  • HMDB15628
Metabolite Identification
Common NameUdenafil
DescriptionUdenafil belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. Based on a literature review very few articles have been published on Udenafil.
Structure
Data?1582753317
Synonyms
ValueSource
DA-8159udenafilChEMBL, HMDB
ZidenaMeSH, HMDB
3-(1-Methyl-7-oxo-3-propyl-4,7-dihydro-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-N-(2-(1-methyl-2-pyrrolidinyl)ethyl)-4-propoxybenzenesulfonamideMeSH, HMDB
Chemical FormulaC25H36N6O4S
Average Molecular Weight516.656
Monoisotopic Molecular Weight516.25187436
IUPAC Name3-{1-methyl-7-oxo-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-5-yl}-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzene-1-sulfonamide
Traditional Nameudenafil
CAS Registry Number268203-93-6
SMILES
CCCOC1=C(C=C(C=C1)S(=O)(=O)NCCC1CCCN1C)C1=NC(=O)C2=C(N1)C(CCC)=NN2C
InChI Identifier
InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)
InChI KeyIYFNEFQTYQPVOC-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzenesulfonamides
Direct ParentBenzenesulfonamides
Alternative Parents
Substituents
  • Benzenesulfonamide
  • Benzenesulfonyl group
  • Pyrazolopyrimidine
  • Phenoxy compound
  • Phenol ether
  • Alkyl aryl ether
  • Pyrimidone
  • Organosulfonic acid amide
  • N-alkylpyrrolidine
  • Pyrimidine
  • Azole
  • Pyrrolidine
  • Vinylogous amide
  • Heteroaromatic compound
  • Aminosulfonyl compound
  • Sulfonyl
  • Pyrazole
  • Organosulfonic acid or derivatives
  • Organic sulfonic acid or derivatives
  • Tertiary aliphatic amine
  • Tertiary amine
  • Ether
  • Azacycle
  • Organoheterocyclic compound
  • Organic oxide
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic nitrogen compound
  • Organopnictogen compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Amine
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.08 g/LNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.08 g/LALOGPS
logP3.2ALOGPS
logP1.66ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)7.21ChemAxon
pKa (Strongest Basic)8.48ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area117.92 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity153.11 m³·mol⁻¹ChemAxon
Polarizability56.34 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+216.51731661259
DarkChem[M-H]-216.22431661259
DeepCCS[M+H]+218.73230932474
DeepCCS[M-H]-216.33730932474
DeepCCS[M-2H]-249.22530932474
DeepCCS[M+Na]+224.64530932474
AllCCS[M+H]+220.032859911
AllCCS[M+H-H2O]+218.432859911
AllCCS[M+NH4]+221.432859911
AllCCS[M+Na]+221.832859911
AllCCS[M-H]-208.932859911
AllCCS[M+Na-2H]-210.732859911
AllCCS[M+HCOO]-212.732859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
UdenafilCCCOC1=C(C=C(C=C1)S(=O)(=O)NCCC1CCCN1C)C1=NC(=O)C2=C(N1)C(CCC)=NN2C5335.7Standard polar33892256
UdenafilCCCOC1=C(C=C(C=C1)S(=O)(=O)NCCC1CCCN1C)C1=NC(=O)C2=C(N1)C(CCC)=NN2C4128.5Standard non polar33892256
UdenafilCCCOC1=C(C=C(C=C1)S(=O)(=O)NCCC1CCCN1C)C1=NC(=O)C2=C(N1)C(CCC)=NN2C4399.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Udenafil,1TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C)C=C1C1=NC(=O)C2=C([NH]1)C(CCC)=NN2C4175.4Semi standard non polar33892256
Udenafil,1TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C)C=C1C1=NC(=O)C2=C([NH]1)C(CCC)=NN2C4085.6Standard non polar33892256
Udenafil,1TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C)C=C1C1=NC(=O)C2=C([NH]1)C(CCC)=NN2C5661.9Standard polar33892256
Udenafil,1TMS,isomer #2CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C4211.2Semi standard non polar33892256
Udenafil,1TMS,isomer #2CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C3949.4Standard non polar33892256
Udenafil,1TMS,isomer #2CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C5523.2Standard polar33892256
Udenafil,2TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C4187.5Semi standard non polar33892256
Udenafil,2TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C4139.5Standard non polar33892256
Udenafil,2TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C5347.2Standard polar33892256
Udenafil,1TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C(C)(C)C)C=C1C1=NC(=O)C2=C([NH]1)C(CCC)=NN2C4346.2Semi standard non polar33892256
Udenafil,1TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C(C)(C)C)C=C1C1=NC(=O)C2=C([NH]1)C(CCC)=NN2C4314.1Standard non polar33892256
Udenafil,1TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C(C)(C)C)C=C1C1=NC(=O)C2=C([NH]1)C(CCC)=NN2C5635.3Standard polar33892256
Udenafil,1TBDMS,isomer #2CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C(C)(C)C4339.3Semi standard non polar33892256
Udenafil,1TBDMS,isomer #2CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C(C)(C)C4189.4Standard non polar33892256
Udenafil,1TBDMS,isomer #2CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C(C)(C)C5495.3Standard polar33892256
Udenafil,2TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C(C)(C)C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C(C)(C)C4493.1Semi standard non polar33892256
Udenafil,2TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C(C)(C)C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C(C)(C)C4595.8Standard non polar33892256
Udenafil,2TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N(CCC2CCCN2C)[Si](C)(C)C(C)(C)C)C=C1C1=NC(=O)C2=C(C(CCC)=NN2C)N1[Si](C)(C)C(C)(C)C5316.3Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Udenafil GC-MS (Non-derivatized) - 70eV, Positivesplash10-001i-9004400000-0342835bf35ef730c22f2017-09-01Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 10V, Positive-QTOFsplash10-014i-0502590000-b8e11c030d243ed9d2592016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 20V, Positive-QTOFsplash10-03di-2902100000-1a5a00b67efbf2897bc42016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 40V, Positive-QTOFsplash10-01ox-9420000000-74342329d4b68016851f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 10V, Negative-QTOFsplash10-014i-1000890000-c6ce8e05963a97f98fc02016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 20V, Negative-QTOFsplash10-00y4-0204910000-ac36068e0c8678f82b522016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 40V, Negative-QTOFsplash10-01pp-9627500000-c5a8d04ca1b9859c3ba92016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 10V, Positive-QTOFsplash10-014i-0000090000-808fd4cfd257e0486ea82021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 20V, Positive-QTOFsplash10-02w9-8705790000-597ac262d3985e25eddd2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 40V, Positive-QTOFsplash10-003s-9510110000-58ff2a93c1476238e6aa2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 10V, Negative-QTOFsplash10-014i-0000090000-84d459a88ad36eccbadc2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 20V, Negative-QTOFsplash10-01b9-0006890000-91252ab893a5dad5a8962021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Udenafil 40V, Negative-QTOFsplash10-000f-0009300000-b1c8416cfb38c62dd54d2021-10-11Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB06267 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB06267 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB06267
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID5293720
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkUdenafil
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Ku HY, Ahn HJ, Seo KA, Kim H, Oh M, Bae SK, Shin JG, Shon JH, Liu KH: The contributions of cytochromes P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors sildenafil, udenafil, and vardenafil. Drug Metab Dispos. 2008 Jun;36(6):986-90. doi: 10.1124/dmd.107.020099. Epub 2008 Feb 28. [PubMed:18308836 ]
  2. Ji HY, Shim HJ, Yoo M, Park ES, Lee HS: Transport of a new erectogenic udenafil in Caco-2 cells. Arch Pharm Res. 2007 Sep;30(9):1168-73. [PubMed:17958337 ]

Enzymes

General function:
Involved in catalytic activity
Specific function:
Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP.
Gene Name:
PDE5A
Uniprot ID:
O76074
Molecular weight:
99984.14
References
  1. Gur S, Sikka SC, Hellstrom WJ: Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stress. Expert Opin Investig Drugs. 2008 Jun;17(6):855-64. doi: 10.1517/13543784.17.6.855 . [PubMed:18491987 ]
  2. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  3. Ahn GJ, Chung HK, Lee CH, Kang KK, Ahn BO: Increased expression of the nitric oxide synthase gene and protein in corpus cavernosum by repeated dosing of udenafil in a rat model of chemical diabetogenesis. Asian J Androl. 2009 Jul;11(4):435-42. doi: 10.1038/aja.2009.27. Epub 2009 May 25. [PubMed:19465935 ]
  4. Zhao C, Kim SH, Lee SW, Jeon JH, Kang KK, Choi SB, Park JK: Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int. 2011 Jun;107(12):1943-7. doi: 10.1111/j.1464-410X.2010.09759.x. Epub 2010 Nov 5. [PubMed:21054754 ]
  5. Kouvelas D, Goulas A, Papazisis G, Sardeli C, Pourzitaki C: PDE5 inhibitors: in vitro and in vivo pharmacological profile. Curr Pharm Des. 2009;15(30):3464-75. [PubMed:19860692 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide.
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular weight:
57255.585
References
  1. Ji HY, Lee HW, Kim HH, Kim DS, Yoo M, Kim WB, Lee HS: Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic. Xenobiotica. 2004 Nov-Dec;34(11-12):973-82. [PubMed:15801542 ]
  2. Ku HY, Ahn HJ, Seo KA, Kim H, Oh M, Bae SK, Shin JG, Shon JH, Liu KH: The contributions of cytochromes P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors sildenafil, udenafil, and vardenafil. Drug Metab Dispos. 2008 Jun;36(6):986-90. doi: 10.1124/dmd.107.020099. Epub 2008 Feb 28. [PubMed:18308836 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
Gene Name:
CYP3A5
Uniprot ID:
P20815
Molecular weight:
57108.065
References
  1. Ku HY, Ahn HJ, Seo KA, Kim H, Oh M, Bae SK, Shin JG, Shon JH, Liu KH: The contributions of cytochromes P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors sildenafil, udenafil, and vardenafil. Drug Metab Dispos. 2008 Jun;36(6):986-90. doi: 10.1124/dmd.107.020099. Epub 2008 Feb 28. [PubMed:18308836 ]